ARLINGTON, Va. – National Association of Chain Drug Stores (NACDS) president and CEO Steven Anderson issued the following statement Tuesday:
“Words like ‘continuing resolution,’ ‘budget reconciliation,’ and ‘standalone bill’ are the words of Washington, DC. While all of these legislative vehicles are sorted out, one fact remains: pharmacy benefit manager (PBM) reform remains a long overdue need and the costs of inaction continue to ravage Americans, their pharmacies, and their communities.
“Every day, Americans are living with the acceleration of prescription drug price inflation and the closing of trusted and convenient pharmacies.At the hands of the PBM middlemen, nearly four pharmacies are closing each day – at an increasing rate. Americans have missed out on hundreds of millions of dollars of savings just since the last Congress ended. The costs of inaction on PBM reform are massive and they are growing, all while the PBMs redouble their revenue.
"Meanwhile, Congress has reforms ready to go – a sound package that was finalized last December. Americans need this win and it is time to deliver it to them. As Congress and the Administration figure out the legislative roadmap, PBM reform needs to get done without further needless delay.”
More information is available on a new NACDS fact sheet.
NACDS: A legislative vehicle must include PBM reform; inaction is costing Americans
Nearly four pharmacies are closing every day; Americans are missing out on hundreds of millions in savings just since the last Congress' end.
Latest
CHPA marks International Self-Care Day
CHPA said self-care interventions save an estimated 1.3 billion hours and $31.8 billion in healthcare-related costs annually across North America.
Théa, Unither Pharmaceuticals announce industrial partnership around new ophthalmic production unit in Auvergne
Under this agreement, the new production unit. located at the Gannat site (Allier), will be primarily dedicated to the manufacture of Théa’s sterile ophthalmic products.
NCPA urges CMS to tighten PBM reform rules
The association is calling on CMS to ensure new Medicare Part D regulations prevent PBMs from exploiting loopholes and provide fair reimbursement for independent pharmacies.
Peptide users embrace self-care as healthcare trust declines
A survey of peptide users found skepticism toward traditional healthcare, with most relying on independent research, scientific literature, and online communities for health decisions.